Chang David D

President and CEO at ALLO; EVP, R&D, Chief Medical Off. at Kite Pharma, Inc.

Sold, on record
$16.7M
Dollars the filings state
Form 4 sales
19
Latest Mar 16, 2026
Form 144 notices
3
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
2
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale ALLOPlan not stated
    Mar 15, 2022 2022

    Sold 23,648 shares at $7.65 ($181k)

    Chang David D, President and CEO

    Sold 1% of holdings ($17.7M position)2.3M shares leftFiling

  2. 2 Form 144 notice ALLONotice
    Mar 14, 2024 +730 days

    Filed to sell 53,393 shares ($231k)

    Chang David D, Officer

    No 10b5-1 planFiling

  3. 3 Form 144 notice ALLONotice
    Feb 3, 2025 +326 days

    Filed to sell 46,003 shares ($77k)

    Chang David D, Officer

    No 10b5-1 planFirst sale on recordFiling

  4. 4 Form 4 sale ALLONo plan
    Feb 3, 2025 same day

    Sold 46,003 shares at $1.68 ($77k)

    Chang David D, President and CEO

    No 10b5-1 planSold 0.9% of holdings ($9M position)5.3M shares leftFirst sale on recordFollows a Form 144Filing

  5. 5 Form 144 notice ALLONotice
    Mar 14, 2025 +39 days

    Filed to sell 46,668 shares ($91k)

    Chang David D, Officer

    No 10b5-1 planFiling

  6. 6 Form 4 sale ALLONo plan
    Mar 14, 2025 same day

    Sold 46,668 shares at $1.96 ($91k)

    Chang David D, President and CEO

    No 10b5-1 planSold 0.9% of holdings ($10.4M position)5.3M shares leftFollows a Form 144Filing

  7. 7 Form 4 sale ALLONo plan
    Feb 2, 2026 +325 days

    Sold 95,269 shares at $1.80 ($171k)

    Chang David D, President and CEO

    No 10b5-1 planSold 1.8% of holdings ($9.5M position)5.2M shares leftFiling

  8. 8 Form 4 sale ALLONo plan
    Mar 16, 2026 +42 days

    Sold 47,763 shares at $2.47 ($118k)

    Chang David D, President and CEO

    No 10b5-1 planSold 0.9% of holdings ($12.8M position)5.2M shares left1x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (22)

Form 144 notices and Form 4 sales by Chang David D
Source
Mar 16, 2026Mar 18, 2026ALLOPresident and CEOForm 4 sale47,763$118k0.9%No planSEC
Feb 2, 2026Feb 4, 2026ALLOPresident and CEOForm 4 sale95,269$171k1.8%No planSEC
Mar 14, 2025Mar 18, 2025ALLOPresident and CEOForm 4 sale46,668$91k0.9%No planSEC
Mar 14, 2025Mar 14, 2025ALLOOfficerForm 144 notice46,668$91kNoticeSEC
Feb 3, 2025Feb 5, 2025ALLOPresident and CEOForm 4 sale46,003$77k0.9%No planSEC
Feb 3, 2025Feb 3, 2025ALLOOfficerForm 144 notice46,003$77kNoticeSEC
Mar 14, 2024Mar 14, 2024ALLOOfficerForm 144 notice53,393$231kNoticeSEC
Mar 15, 2022Mar 17, 2022ALLOPresident and CEOForm 4 sale23,648$181k1.0%Plan not statedSEC
Mar 15, 2021Mar 17, 2021ALLOPresident and CEOForm 4 sale20,513$791k0.9%Plan not statedSEC
Mar 16, 2020Mar 18, 2020ALLOPresident and CEOForm 4 sale20,335$393k0.9%Plan not statedSEC
Sep 25, 2017Sep 27, 2017Kite Pharma, Inc.EVP, R&D, Chief Medical Off.Form 4 sale7,927$1.4M12.1%Plan not statedSEC
May 1, 2017May 3, 2017Kite Pharma, Inc.EVP, R&D, Chief Medical Off.Form 4 sale20,000$1.6M28.5%UnusualSEC
Apr 3, 2017Apr 4, 2017Kite Pharma, Inc.EVP, R&D, Chief Medical Off.Form 4 sale20,000$1.6M28.5%UnusualSEC
Mar 1, 2017Mar 2, 2017Kite Pharma, Inc.EVP, R&D, Chief Medical Off.Form 4 sale60,000$4.7M54.5%UnusualSEC
Dec 20, 2016Dec 22, 2016Kite Pharma, Inc.EVP, R&D, Chief Medical Off.Form 4 sale1,788$91k6.6%Plan not statedSEC
Nov 10, 2015Nov 12, 2015Kite Pharma, Inc.EVP, R&D, Chief Medical Off.Form 4 sale30,800$2.5M81.7%UnusualSEC
Nov 2, 2015Nov 4, 2015Kite Pharma, Inc.EVP, R&D, Chief Medical Off.Form 4 sale7,700$547k52.7%UnusualSEC
Oct 1, 2015Oct 2, 2015Kite Pharma, Inc.EVP, R&D, Chief Medical Off.Form 4 sale7,700$424k52.7%UnusualSEC
Sep 8, 2015Sep 8, 2015Kite Pharma, Inc.EVP, R&D, Chief Medical Off.Form 4 sale7,700$424k52.7%UnusualSEC
Aug 3, 2015Aug 4, 2015Kite Pharma, Inc.EVP, R&D, Chief Medical Off.Form 4 sale7,700$555k56.2%UnusualSEC
Jul 1, 2015Jul 2, 2015Kite Pharma, Inc.EVP, R&D, Chief Medical Off.Form 4 sale7,700$477k56.2%UnusualSEC
Jun 15, 2015Jun 17, 2015Kite Pharma, Inc.EVP, R&D, Chief Medical Off.Form 4 sale7,700$439k56.2%UnusualSEC